Top 73 medical and healthcare startups in Canada
Feb 09, 2026
|
Like
17
2
Funding: $887M
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
3
Funding: $360.9M
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
4
Funding: $326.2M
Profound Medical manufactures a device for MRI-guided transurethral ultrasound ablation of the prostate cancer. TULSA-PRO is an FDA/CE-cleared surgical robot for ablation in men with localized prostate cancer, associated with obstructive benign prostatic hyperplasia (BPH), localized recurrent prostate cancer after radiation therapy or large-volume BPH. The system enables preoperative surgical planning, 360-degree guidance, precise and accurate targeting, automatic energy adjustment and real-time temperature monitoring.
Profound Medical manufactures a device for MRI-guided transurethral ultrasound ablation of the prostate cancer. TULSA-PRO is an FDA/CE-cleared surgical robot for ablation in men with localized prostate cancer, associated with obstructive benign prostatic hyperplasia (BPH), localized recurrent prostate cancer after radiation therapy or large-volume BPH. The system enables preoperative surgical planning, 360-degree guidance, precise and accurate targeting, automatic energy adjustment and real-time temperature monitoring.
5
Funding: $293.4M
AlayaCare delivers an end-to-end home health care software platform and hardware ecosystem for patients.
AlayaCare delivers an end-to-end home health care software platform and hardware ecosystem for patients.
6
Funding: $271.1M
League is a digital health platform that connects people to a comprehensive network of health services and benefits.
League is a digital health platform that connects people to a comprehensive network of health services and benefits.
7
Funding: $267M
Fullscript is a supplement dispensing platform and patient adherence tool that supports practitioners at the point of care and beyond.
Fullscript is a supplement dispensing platform and patient adherence tool that supports practitioners at the point of care and beyond.
8
Funding: $259M
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
9
Funding: $251.7M
Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
10
Funding: $236.7M
Deep Genomics brings together world-leading expertise in machine learning and genome biology. We’re inventing a new generation of computational technologies that predict what will happen within a cell when DNA is altered by genetic variation, whether natural or therapeutic. Our systems predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.
Deep Genomics brings together world-leading expertise in machine learning and genome biology. We’re inventing a new generation of computational technologies that predict what will happen within a cell when DNA is altered by genetic variation, whether natural or therapeutic. Our systems predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.
11
Funding: $225M
BlueRock Therapeutics is pioneering cell therapies that replace dead, damaged, or dysfunctional cells to restore critical natural functions in the body. The company is initially targeting severe brain and heart conditions, two areas of critical unmet medical need with blockbuster potential.
BlueRock Therapeutics is pioneering cell therapies that replace dead, damaged, or dysfunctional cells to restore critical natural functions in the body. The company is initially targeting severe brain and heart conditions, two areas of critical unmet medical need with blockbuster potential.
12
Funding: $196.1M
Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering. We bring together a multi-talented team of individuals to develop cutting-edge custom human tissue technology for use in the life sciences.
Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering. We bring together a multi-talented team of individuals to develop cutting-edge custom human tissue technology for use in the life sciences.
13
Funding: $148.3M
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
14
Funding: $133M
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
15
Funding: $120.1M
Oncolytics Biotech is developing REOLYSIN®, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.
Oncolytics Biotech is developing REOLYSIN®, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.
16
Funding: $101.6M
Congruence Therapeutics is building a team of 'drug hunters' to go after rare disease targets
Congruence Therapeutics is building a team of 'drug hunters' to go after rare disease targets
17
Funding: $76.8M
Felix is a digital healthcare company providing seamless access to medication through online diagnoses and delivery.
Felix is a digital healthcare company providing seamless access to medication through online diagnoses and delivery.
18
Funding: $71.7M
Maple's mission is to tackle some of the world’s most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers – so that you can feel better, faster.
Maple's mission is to tackle some of the world’s most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers – so that you can feel better, faster.
19
Funding: $65M
Smile CDR makes it easy for healthcare stakeholders to collect and exchange data with our leading FHIR-based data liberation platform.
Smile CDR makes it easy for healthcare stakeholders to collect and exchange data with our leading FHIR-based data liberation platform.
20
Funding: $56.1M
Swift Medical develops an app that is able to capture wound care information by waving the smartphone above the injured site in a wand-like fashion.
Swift Medical develops an app that is able to capture wound care information by waving the smartphone above the injured site in a wand-like fashion.
21
Funding: $55.5M
PocketHealth is a cloud platform that focuses on sharing medical images.
PocketHealth is a cloud platform that focuses on sharing medical images.
22
Funding: $53.9M
Synaptive Medical is a medical device manufacturing company that specializes in neurosurgery, medical imaging, and surgical navigation.
Synaptive Medical is a medical device manufacturing company that specializes in neurosurgery, medical imaging, and surgical navigation.
23
Funding: $50.9M
Tech Driven Pharmacy that delivers your medication straight to your door.
Tech Driven Pharmacy that delivers your medication straight to your door.
24
Funding: $48M
Vital is reimagining lab testing to enable radically accessible care.
Vital is reimagining lab testing to enable radically accessible care.
25
Funding: $39.9M
InteraXon is the maker of brainwave-controlled computing technology and applications. It has created a hardware and software platform technology which converts brainwaves into digital signals that are fed into a computer. InteraXon provides consumers with applications that use these brainwaves to perform activities such as; meditation, gaming, ADHD assistance, and many others to come.
InteraXon is the maker of brainwave-controlled computing technology and applications. It has created a hardware and software platform technology which converts brainwaves into digital signals that are fed into a computer. InteraXon provides consumers with applications that use these brainwaves to perform activities such as; meditation, gaming, ADHD assistance, and many others to come.
26
Funding: $40M
Gandeeva Therapeutics is a precision biotechnology company harnessing the power of cryogenic electron microscopy and machine learning.
Gandeeva Therapeutics is a precision biotechnology company harnessing the power of cryogenic electron microscopy and machine learning.
27
Funding: $35.4M
Medical Device startup developing a solution to detect gastrointestinal leaks after surgical procedures.
Medical Device startup developing a solution to detect gastrointestinal leaks after surgical procedures.
28
Funding: $32.7M
CloudDX offers a range of precision vital sign monitoring equipment, software solutions, and mobile apps for the advanced healthcare industry.
CloudDX offers a range of precision vital sign monitoring equipment, software solutions, and mobile apps for the advanced healthcare industry.
29
Funding: $23.5M
Discover compelling medical cases. Global community focused on education and collaboration. Used by 500,000+ healthcare professionals and students. Built-in patient privacy tools
Discover compelling medical cases. Global community focused on education and collaboration. Used by 500,000+ healthcare professionals and students. Built-in patient privacy tools
30
Funding: $25.2M
Optina Diagnostics develops technology for the early detection of disease through the eye.
Optina Diagnostics develops technology for the early detection of disease through the eye.
31
Funding: $24M
Tia Health is building a network of holistic health clinics and virtual services for women
Tia Health is building a network of holistic health clinics and virtual services for women
32
Funding: CA$31.4M
Felix is a digital healthcare company providing seamless access to medication through online diagnoses and delivery.
Felix is a digital healthcare company providing seamless access to medication through online diagnoses and delivery.
33
Funding: $20.7M
eSight is the only patented, assistive-device of its kind anywhere in the world. eSight is wearable, handsfree, portable - and most importantly, eSight is a non-surgical device. eSight is currently registered with the United States FDA and Health Canada.
eSight is the only patented, assistive-device of its kind anywhere in the world. eSight is wearable, handsfree, portable - and most importantly, eSight is a non-surgical device. eSight is currently registered with the United States FDA and Health Canada.
34
Funding: $17.6M
MedChart is a release of information platform that makes transfer of medical records easy and secure on the cloud.
MedChart is a release of information platform that makes transfer of medical records easy and secure on the cloud.
35
Funding: $16.5M
Sound Blade Medical is an early stage medical device startup which transforms healthcare by developing endoscopic, image-guided histotripsy.
Sound Blade Medical is an early stage medical device startup which transforms healthcare by developing endoscopic, image-guided histotripsy.
37
Funding: $13.3M
AssistIQ is a accurate data & actionable insights for healthcare supply management.
AssistIQ is a accurate data & actionable insights for healthcare supply management.
38
Funding: $11.4M
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.
39
Funding: $10.7M
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.
40
Funding: CA$14.4M
Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line.
Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line.
41
Funding: $10.3M
The Rounds is the secure collaboration network modern physicians trust to improve healthcare outcomes. Physicians of all specialties use The Rounds to learn, share and discuss their needs in a secure environment.
The Rounds is the secure collaboration network modern physicians trust to improve healthcare outcomes. Physicians of all specialties use The Rounds to learn, share and discuss their needs in a secure environment.
42
Funding: CA$14M
Grey Matter Neurosciences develops new medical devices and drug-device combinations to treat age-related brain illnesses.
Grey Matter Neurosciences develops new medical devices and drug-device combinations to treat age-related brain illnesses.
43
Funding: $8M
Twig Fertility operates as a fertility clinic and reproductive health company.
Twig Fertility operates as a fertility clinic and reproductive health company.
44
Funding: $6.8M
Patented, AI-Powered, mobile software, eye tracking technology that captures digital Eye Movement Biomarkers to monitor disease status & progression in neurodegenerative and mental disorders.
Patented, AI-Powered, mobile software, eye tracking technology that captures digital Eye Movement Biomarkers to monitor disease status & progression in neurodegenerative and mental disorders.
45
Funding: $6.6M
Afynia Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties.
Afynia Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties.
46
Funding: $5.2M
WinterLight Labs develops a novel AI technology that can quickly and accurately quantify speech and language patterns to help detect and monitor cognitive and mental diseases.
WinterLight Labs develops a novel AI technology that can quickly and accurately quantify speech and language patterns to help detect and monitor cognitive and mental diseases.
47
Funding: CA$6.8M
Nanostics is focused on development and commercialization of novel, non-invasive diagnostic tests for cancer.
Nanostics is focused on development and commercialization of novel, non-invasive diagnostic tests for cancer.
48
Funding: $4.1M
SeamlessMD provides a cloud-based platform for hospitals to educate, engage and monitor patients through surgery
SeamlessMD provides a cloud-based platform for hospitals to educate, engage and monitor patients through surgery
49
Funding: $3.3M
Wellin5 is a one-stop solution to access online counseling & post-therapy support.
Wellin5 is a one-stop solution to access online counseling & post-therapy support.
50
Funding: CA$3.8M
For a half century, ophthalmic surgeons have envisioned an intraocular lens capable of restoring eyesight at all distances. Ocumetics Technology Corporation was founded to achieve this goal. Employing state-of-the art materials and production techniques, Ocumetics Technology Corporation is in the process of developing a highly advanced intraocular lens, one that is capable of restoring clear vision at all distances, without glasses or contact lenses, and without the visual quality problems that have plagued current accommodative and multifocal intraocular lens designs.
For a half century, ophthalmic surgeons have envisioned an intraocular lens capable of restoring eyesight at all distances. Ocumetics Technology Corporation was founded to achieve this goal. Employing state-of-the art materials and production techniques, Ocumetics Technology Corporation is in the process of developing a highly advanced intraocular lens, one that is capable of restoring clear vision at all distances, without glasses or contact lenses, and without the visual quality problems that have plagued current accommodative and multifocal intraocular lens designs.
